VALEO PHARMA INC 12% DEB CNV SUB 31 12% DEB CNV SUB 31/12/2024VALEO PHARMA INC 12% DEB CNV SUB 31 12% DEB CNV SUB 31/12/2024VALEO PHARMA INC 12% DEB CNV SUB 31 12% DEB CNV SUB 31/12/2024

VALEO PHARMA INC 12% DEB CNV SUB 31 12% DEB CNV SUB 31/12/2024

No trades
See on Supercharts

VPH.DB analysis



Key facts


Issue date
Dec 9, 2021
Maturity date
Dec 31, 2024
Outstanding amount
‪16.50 M‬CAD
Face value
1,000.00CAD
Minimum denomination
1,000.00CAD
Coupon
12.00% (Fixed)
Yield to maturity
34.25%
Valeo Pharma, Inc. engages in the acquisition and in-licensing of branded pharmaceutical and hospital specialty products for sale. Its product portfolio includes respiratory/allergy, specialty products, ophthalmology, neurology, and oncology. The company was founded by Steven Saviuk on March 27, 2003 and is headquartered in Kirkland, Canada.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.